Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Blood|August 1, 2002
Regulation of iron absorption in Hfe mutant miceRichard S Ajioka, Joanne E Levy, Nancy C Andrews, et al.Genetics|September 25, 2003
A method for detecting recent selection in the human genome from allele age estimatesChristopher Toomajian, Richard S Ajioka, Lynn B Jorde, et al.Blood|December 7, 2006
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyriaJohn D Phillips, David P Steensma, Michael A Pulsipher, et al.Journal of Molecular Biology|April 14, 2009
Substrate shuttling between active sites of uroporphyrinogen decarboxylase is not required to generate coproporphyrinogenJohn D Phillips, Christy A Warby, Frank G Whitby, et al.Blood|May 13, 2004
Identification of a novel mutation (C321X) in HJVFranklin W Huang, Isabel Rubio-Aliaga, James P Kushner, et al.Blood Cells, Molecules & Diseases|May 12, 2007
Mapping genes responsible for strain-specific iron phenotypes in murine chromosome substitution strainsRichard S Ajioka, Renee C LeBoeuf, Ryan R Gillespie, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tardaJohn D Phillips, Hector A Bergonia, Christopher A Reilly, et al.Blood|August 30, 2007
Zebrafish as a model for defining the functional impact of mammalian ferroportin mutationsIvana De Domenico, Michael B Vaughn, Donghoon Yoon, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|January 24, 2007
Two novel uroporphyrinogen decarboxylase (URO-D) mutations causing hepatoerythropoietic porphyria (HEP)John D Phillips, Frank G Whitby, Beth M Stadtmueller, et al.Leukemia Research|June 4, 2015
Phase I trial of low-dose oral Clofarabine in myelodysplastic syndromes patients who have failed frontline therapyVenkatesh K Rudrapatna, Kimberly Morley, Kenneth M Boucher, et al.Pageof 3